TLR4 and myelodysplastic syndrome: Elevated levels of toll like receptor 4 (TLR4) and TNF receptor-associated factor 6 (TRAF6) have been identified in hematopoietic stem/progenitor cells of MDS patients, contributing to the hyperactivation of the NLRP3 inflammasome via NF-κB [106].